STAGE III

Clinical trials for STAGE III explained in plain language.

Never miss a new study

Get alerted when new STAGE III trials appear

Sign up with your email to follow new studies for STAGE III, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New combo targets hard-to-treat lung cancer in early trial

Disease control Not yet recruiting

This study tests a drug called firmonertinib combined with radiation therapy for people with stage III lung cancer that has specific genetic changes (EGFR uncommon mutations) and cannot be removed by surgery. The goal is to see if the combination can delay cancer growth or improv…

Matched conditions: STAGE III

Phase: PHASE2 • Sponsor: Hunan Cancer Hospital • Aim: Disease control

Last updated May 17, 2026 13:54 UTC

STAGE III

Get alerted when new STAGE III trials appear

New combo targets hard-to-treat lung cancer in early trial